{
    "symbol": "MIRO",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-15 20:18:04",
    "content": " Following IND clearance from the FDA, we plan to initiate a Phase 1 clinical trial. This quarter, the FDA hosted a public advisory committee meeting to discuss scientific and regulatory topics relating to the organ transplant field, specifically xenotransplantation, Miromatrix and the medical community are excited about the potential of xenotransplantation to some day save and improve the lives of patients suffering from any stage organ failure. Following IND clearance from the FDA, we plan to initiate a Phase 1 clinical trial."
}